Anti-Human CD35 (E11)
CD35 Monoclonal Antibody for FC, ELISA
Host / Isotype
Mouse / IgG1, kappa
Reactivity
Human
Applications
FC, ELISA
Conjugate
Unconjugated
CloneNo.
E11
Cat no : 65254-1-Ig
Synonyms
Validation Data Gallery
Tested Applications
Positive FC detected in | human PBMCs |
Recommended dilution
Application | Dilution |
---|---|
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
65254-1-Ig targets CD35 in FC, ELISA applications and shows reactivity with Human samples.
Tested Reactivity | Human |
Host / Isotype | Mouse / IgG1, kappa |
Class | Monoclonal |
Type | Antibody |
Immunogen | Human CD35 from Acute monocytic leukemia cells and normal blood monocytes |
Full Name | complement component (3b/4b) receptor 1 (Knops blood group) |
Calculated Molecular Weight | 224 kDa |
GenBank Accession Number | NM_000573 |
Gene Symbol | CR1 |
Gene ID (NCBI) | 1378 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Affinity purification |
Storage Buffer | PBS with 0.09% sodium azide. |
Storage Conditions | Store at 2-8°C. Stable for one year after shipment. |
Background Information
CD35, also known as complement receptor type 1 (CR1) or C3b/C4b receptor, is a single-chain glycoprotein consisting of 30 repeating homologous protein domains known as short consensus repeats (~60 amino acids each) followed by transmembrane and cytoplasmic domains (PMID: 8765013). CD35 is variably expressed by granulocytes, monocytes, B cells, some T cells, erythrocytes, follicular dendritic cells, Langerhans cells, and glomerular podocytes (PMID: 19004497). CD35 acts as a receptor for C3b and C4b and plays important roles in the regulation of the complement cascade and clearance of immune complexes.
Protocols
Product Specific Protocols | |
---|---|
FC protocol for CD35 antibody 65254-1-Ig | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |